Differential Antineoplastic Effects of Butyrate in Cells With and Without a Functioning DNA Mismatch Repair

作者：Dronamraju Shridhar S; Coxhead Jonathan M; Kelly Seamus B; Mathers John C^*

来源：Nutrition and Cancer-An International Journal, 2010, 62(1): 105-115.

DOI：10.1080/01635580903191486

The aim of this study was to investigate the differential antineoplastic effects of butyrate in cells with and without a functional mismatch repair and to determine the molecular mechanisms underlying these effects. SW48 colon cancer cells in which the MLH1 gene is silenced by promoter hypermethylation and demethylated SW48 cells in which the MLH1 gene is reexpressed were treated with butyrate (0-5mM) for 8 days and the effects on cell number, MLH1 gene promoter methylation, and expression of two cell cycle regulatory genes, CDK4 and GADD45A, were assessed. Butyrate suppressed viable cell number (P 0.001) and reduced MLH1 promoter methylation (P 0.05) in SW48 cells. However, in demethylated SW48 cells, butyrate caused an increase in viable cells (P 0.05) and promoter methylation (P 0.05). CDK4 expression was downregulated by butyrate exposure, but the effect was significantly greater for demethylated SW48 cells (P = 0.025). Butyrate treatment caused upregulation of GADD45A expression in SW48 cells but downregulation of GADD45A expression in demethylated SW48 cells (P = 0.045). This study supports the hypothesis that butyrate has more potent antineoplastic effects on colon cancer cells with MLH1 dysfunction. Differential expression of key cell cycle regulatory genes may explain some of the molecular mechanisms underlying these effects.

• 出版日期2010